Tom Duthy
Follow
Get notifications in MyBN when activity occurs.
Tom Duthy
Executive Director, Investor Relations & Strategic Corporate Development / Neurotech International
Most Notable Role
Dr Thomas Duthy has financial market experience in corporate transactions, and held senior executive roles with S&P/ASX Top 100 companies.
Dr Duthy is the founder and chief executive of Nemean Group, an Adelaide-based boutique corporate advisory and investor relations company for the life sciences and technology sectors.
He was formerly the global head of investor relations & corporate development at Sirtex Medical which was sold to CDH Investments in September 2018, and spent ten years as a sell-side healthcare & biotechnology analyst with a focus on small-cap companies.
Dr Duthy is the founder and chief executive of Nemean Group, an Adelaide-based boutique corporate advisory and investor relations company for the life sciences and technology sectors.
He was formerly the global head of investor relations & corporate development at Sirtex Medical which was sold to CDH Investments in September 2018, and spent ten years as a sell-side healthcare & biotechnology analyst with a focus on small-cap companies.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 45th | 4DS Memory | 177% | 7% |
| 714th | Connected IO | 0% | 0% |
| 1865th | Invex Therapeutics | -83% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
2022
Executive Director, Investor Relations & Strategic Corporate Development
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 175th |  | Invex Therapeutics | $459k |
| 191st |  | Pura Vida Energy | $74k |
| 192nd | | Connected IO | $24k |
| 194th | | 4DS Memory | $0 |
| 195th |  | HearMeOut | $0 |
201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEWS: Tagged in Neurotech to raise $10m | 17 Apr 2024 |
| NEWS: Tagged in Board Moves February 5, 2024 | 05 Feb 2024 |
| NEW ROLE: Non-Executive Director, PharmAust | 05 Feb 2024 |
| NEW ROLE: Non-Executive Chair, Arovella Therapeutics | 13 Mar 2023 |
| NEW ROLE: Executive Director, Investor Relations & Strategic Corporate Development, Neurotech International | 16 Aug 2022 |
| REMUNERATION UPDATE: Non-Executive Director, Respiri | 13 Nov 2020 |
| NEW ROLE: Non-Executive Director, Respiri | 03 Nov 2020 |
| NEW ROLE: Executive Director, Invex Therapeutics | 10 Oct 2020 |
